X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (29) 29
humans (28) 28
index medicus (23) 23
lung neoplasms - drug therapy (22) 22
carcinoma, non-small-cell lung - drug therapy (18) 18
female (17) 17
male (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
aged (15) 15
middle aged (15) 15
chemotherapy (14) 14
lung neoplasms - pathology (13) 13
lung cancer (10) 10
adult (8) 8
article (8) 8
lung cancer, non-small cell (8) 8
cancer (7) 7
carcinoma, non-small-cell lung - pathology (7) 7
disease-free survival (7) 7
antineoplastic agents - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
cell lung-cancer (6) 6
cisplatin (6) 6
lung neoplasms - genetics (6) 6
metastasis (6) 6
aged, 80 and over (5) 5
apoptosis (5) 5
bevacizumab (5) 5
cancer therapies (5) 5
carcinoma, non-small-cell lung - genetics (5) 5
care and treatment (5) 5
dose-response relationship, drug (5) 5
hematology, oncology and palliative medicine (5) 5
neoplasm staging (5) 5
nivolumab (5) 5
non-small cell lung cancer (5) 5
open-label (5) 5
platinum (5) 5
survival (5) 5
survival rate (5) 5
treatment outcome (5) 5
tumors (5) 5
analysis (4) 4
antibodies, monoclonal - therapeutic use (4) 4
biomarkers, tumor - genetics (4) 4
breast-cancer (4) 4
carcinoma, squamous cell - drug therapy (4) 4
cohort studies (4) 4
docetaxel (4) 4
gemcitabine (4) 4
immunotherapy (4) 4
lung neoplasms - metabolism (4) 4
medicine & public health (4) 4
mutation (4) 4
respiratory system (4) 4
safety (4) 4
therapy (4) 4
trial (4) 4
1st-line treatment (3) 3
adenocarcinoma - drug therapy (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antineoplastic agents - adverse effects (3) 3
b7-h1 antigen - biosynthesis (3) 3
b7-h1 antigen - immunology (3) 3
biomarkers, tumor - metabolism (3) 3
carcinoma, non-small-cell lung - immunology (3) 3
carcinoma, non-small-cell lung - secondary (3) 3
clinical trials (3) 3
combined modality therapy (3) 3
development and progression (3) 3
dna methylation - drug effects (3) 3
drug therapy (3) 3
follow-up studies (3) 3
gefitinib (3) 3
glutamates - administration & dosage (3) 3
guanine - administration & dosage (3) 3
guanine - analogs & derivatives (3) 3
kaplan-meier estimate (3) 3
lung neoplasms - immunology (3) 3
maximum tolerated dose (3) 3
metastases (3) 3
original reports (3) 3
paclitaxel plus carboplatin (3) 3
patients (3) 3
pd-l1 protein (3) 3
pemetrexed (3) 3
pharmacology & pharmacy (3) 3
prognosis (3) 3
receptor, epidermal growth factor - genetics (3) 3
research (3) 3
solid tumors (3) 3
studies (3) 3
abridged index medicus (2) 2
acquired-resistance (2) 2
adenocarcinoma (2) 2
adenocarcinoma - pathology (2) 2
advanced solid tumors (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal, humanized (2) 2
antimetabolites, antineoplastic - pharmacology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Genetics, ISSN 2210-7762, 06/2016, Volume 209, Issue 6, pp. 287 - 287
Journal Article
Biomarkers in Cancer, ISSN 1179-299X, 02/2016, Volume 2016, Issue Suppl. 2, pp. 1 - 13
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2016, Volume 34, Issue 25, pp. 2969 - 2979
Journal Article
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, ISSN 1556-0864, 5/2013, Volume 8, Issue 5, pp. 619 - 623
Journal Article
Oncotarget, ISSN 1949-2553, 2013, Volume 4, Issue 11, pp. 2067 - 2079
Innovative therapies are needed for advanced Non-Small Cell Lung Cancer (NSCLC). We have undertaken a genomics based, hypothesis driving, approach to query an... 
HDAC inhibitor | Non-Small Cell Lung Cancer(NSCLC) | Azacytidine | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. TPS3152 - TPS3152
Journal Article
Cancer Discovery, ISSN 2159-8274, 12/2011, Volume 1, Issue 7, pp. 598 - 607
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 10/2008, Volume 6, Issue 9, pp. 851 - 860
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 05/2013, Volume 8, Issue 5, pp. 619 - 623
Preclinical studies have suggested that the oral antifungal agent itraconazole specifically inhibits proliferation, migration, and tube formation of... 
Antiangiogenic | Lung cancer | Itraconazole | PROGNOSTIC IMPACT | ANGIOGENESIS | BEVACIZUMAB | STATISTICS | CHEMOTHERAPY | ONCOLOGY | RESPIRATORY SYSTEM | GROWTH | EXPRESSION | III TRIAL | Index Medicus
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 09/2018, Volume 13, Issue 9, pp. 1363 - 1372
This phase I study evaluated nivolumab combined with erlotinib in patients with advanced -mutant NSCLC. Patients with advanced -mutant NSCLC who were EGFR... 
Programmed death 1 axis inhibitor | EGFR-mutant NSCLC | Erlotinib | Combination therapy | Nivolumab | 1ST-LINE TREATMENT | ACTIVATION | ADENOCARCINOMA | IMMUNE ESCAPE | OPEN-LABEL | MECHANISMS | CELL LUNG-CANCER | ONCOLOGY | RESPIRATORY SYSTEM | PD-L1 | RESISTANCE | ASSOCIATION | Index Medicus
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2017, Volume 54, pp. 43 - 57
Highlights • Efficacy benefits are observed with EGFR-inhibitors for lung SqCC and SCCHN. • Biomarkers of response to EGFR-inhibitors in lung SqCC and SCCHN... 
Hematology, Oncology and Palliative Medicine | Squamous histology | Biomarkers | Head and neck cancer | EGFR inhibition | Disease management | Lung cancer | CHEMOTHERAPY PLUS CETUXIMAB | OPEN-LABEL | HUMAN-PAPILLOMAVIRUS | OROPHARYNX CANCER | PHASE-III TRIAL | RECEPTOR-TYROSINE KINASE | ONCOLOGY | 2ND-LINE TREATMENT | ERLOTINIB MAINTENANCE THERAPY | 1ST-LINE THERAPY | RETROSPECTIVE ANALYSIS | Lung Neoplasms - drug therapy | ErbB Receptors - antagonists & inhibitors | ErbB Receptors - metabolism | Neoplasms, Squamous Cell - epidemiology | Carcinoma, Squamous Cell - epidemiology | Antibodies, Monoclonal - pharmacology | Humans | ErbB Receptors - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - epidemiology | Treatment Outcome | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - drug therapy | Lung Neoplasms - epidemiology | Head and Neck Neoplasms - epidemiology | Neoplasms, Squamous Cell - drug therapy | Biomarkers, Tumor - metabolism | Biomarkers, Tumor - genetics | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Molecular Targeted Therapy - methods | Prevention | Cancer | Medical research | Squamous cell carcinoma | Epidermal growth factor | Analysis | Medicine, Experimental | Development and progression
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.